Yes, the composition of the microbiome can significantly impact the efficacy of cancer treatments. For example, some bacteria can metabolize chemotherapy drugs, reducing their effectiveness. Conversely, certain microbes can enhance the efficacy of immunotherapies by stimulating the immune system. Understanding these interactions is crucial for developing personalized cancer treatments.
